Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.

作者: F. W. Gibb , G. J. Beckett , M. W. J. Strachan , N. N. Zammitt

DOI: 10.3275/8949

关键词: Weight gainPediatricsPrimary outcomeWeight changeSurgeryConfidence intervalThyroidTreatment failureMedicineRetrospective cohort studyRadioiodine therapy

摘要: Background: Following radioiodine (131I) therapy, both late recognition of hypothyroidism and treatment failure may result in adverse outcomes. Aim: We sought to assess indicators incipient following 131I determine factors predictive weight gain. Subjects methods: Retrospective study 288 patients receiving for Graves’ thyrotoxicosis. Primary outcome measures were thyroid status change at 1 yr 131I. Results: The rate was 13.5%. Hypothyroidism developed 80.9%, with 58.5% having levels free T4 (fT4) 6 pmol/l (p=0.05). main predictor gain fT4 level immediately prior treatment; those the lowest tertile gained a median 3.1 kg whilst highest 7.4 (median difference 4.3 kg; 95% confidence interval: 2.5–6.2). Conclusions: Marked is common often occurs early. Simple biochemical parameters help identify potentially limit excess Treatment severe thyrotoxicosis such cases larger doses be warranted.

参考文章(23)
Núria Gómez, José M. Gómez, Carles Villabona, Amat Orti, Joan Soler, Laura Gavaldà, Pere Leyes, Transient hypothyroidism after iodine-131 therapy for Grave's disease. The Journal of Nuclear Medicine. ,vol. 36, pp. 1539- 1542 ,(1995)
Steen Joop Bonnema, Finn Noe Bennedbæk, Annegrete Veje, Jens Marving, Laszlo Hegedüs, Continuous Methimazole Therapy and Its Effect on the Cure Rate of Hyperthyroidism Using Radioactive Iodine: An Evaluation by a Randomized Trial The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 2946- 2951 ,(2006) , 10.1210/JC.2006-0226
Erik K. Alexander, P. Reed Larsen, High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves’ Disease The Journal of Clinical Endocrinology and Metabolism. ,vol. 87, pp. 1073- 1077 ,(2002) , 10.1210/JCEM.87.3.8333
Derik Hermsen, Martina Broecker-Preuss, Marco Casati, Jordi Camara Mas, Anja Eckstein, Dieter Gassner, Josef van Helden, Keiko Inomata, Jochen Jarausch, Jürgen Kratzsch, Klaus Mann, Naoko Miyazaki, Miguel Angel Navarro Moreno, Tsukasa Murakami, Heinz-Jürgen Roth, Jaeduk Yoshimura Noh, Werner A. Scherbaum, Matthias Schott, Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies Clinica Chimica Acta. ,vol. 401, pp. 84- 89 ,(2009) , 10.1016/J.CCA.2008.11.025
Claudio Marcocci, Fausto Bogazzi, Luca Manetti, Maria Laura Tanda, Enrica Dell'Unto, Gabriella Bruno-Bossio, Marco Nardi, Maria Pia Bartolomei, Antonio Lepri, Giuseppe Rossi, Enio Martino, Aldo Pinchera, Luigi Bartalena, Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy New England Journal of Medicine. ,vol. 338, pp. 73- 78 ,(1998) , 10.1056/NEJM199801083380201
Lloyd D. Hancock, R. Michael Tuttle, Homer LeMar, John Bauman, Troy Patience, The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology. ,vol. 47, pp. 425- 430 ,(1997) , 10.1046/J.1365-2265.1997.2741075.X
Amit Allahabadia, Jacquie Daykin, Michael C. Sheppard, Stephen C. L. Gough, Jayne A. Franklyn, Radioiodine Treatment of Hyperthyroidism—Prognostic Factors for Outcome The Journal of Clinical Endocrinology and Metabolism. ,vol. 86, pp. 3611- 3617 ,(2001) , 10.1210/JCEM.86.8.7781
N. R. Syme, A. D. Toft, M. Stoddart, G. J. Beckett, Clinical performance of the Roche cobas e411 automated assay system for thyrotropin-receptor antibodies for the diagnosis of Graves' disease Annals of Clinical Biochemistry. ,vol. 48, pp. 471- 473 ,(2011) , 10.1258/ACB.2011.011013
J. S. A. SAWERS, A. D. TOFT, W. J. IRVINE, N. S. BROWN, J. SETH, Transient Hypothyroidism after Iodine-131 Treatment of Thyrotoxicosis The Journal of Clinical Endocrinology and Metabolism. ,vol. 50, pp. 226- 229 ,(1980) , 10.1210/JCEM-50-2-226